Specificity and Inhibitory Mechanism of Andrographolide and Its Analogues as Antiasthma Agents on NF-κB p50
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Andrographolide (1) is a diterpenoid lactone with an α,β-unsaturated lactone group that inhibits NF-κB DNA binding. Andrographolide reacts with the nucleophilic Cys62 of NF-κB p50 through a Michael addition at the Δ(12(13)) exocylic double bond to form a covalent adduct. Using computer docking, site-directed mutagenesis, and mass spectrometry, the noncovalent interactions between andrographolide and additional binding site residues other than Cys62 were found to be essential for the covalent incorporation of andrographolide. Furthermore, the addition reaction of andrographolide on Cys62 was highly dependent on the redox conditions and on the vicinity of nearby, positively charged Arg residues in the conserved RxxRxR motif. The reaction mechanisms of several of the analogues were determined, showing that 14-deoxy-11,12-didehydroandrographolide (8) reacts with NF-κB p50 via a novel mechanism distinct from andrographolide. The noncovalent interaction and redox environment of the binding site should be considered, in addition to the electrophilicity, when designing a covalent drug. Analogues similar in structure appear to use distinct reaction mechanisms and may have very different cytotoxicities, e.g., compound 6.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This highlights the important fact that apart from the electrophilicity of the ligand, the redox environment and non-covalent interactions within the binding site should also be taken into account when designing covalent PPI inhibitors.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [78]
In the citing paper
“For example, the natural product andrographolide contains a reaction α,β-unsaturated lactone group, which targeted the nucleophilic Cys62 on the p50 subunit of NF-κB [78].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [78]
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
Barrett, A. J., Kembhavi, A. A., Brown, M. A., Kirschke, H., Knight, C. G., Tamai, M., & Hanada, K. (1982) · Biochemical Journal · doi:10.1042/bj2010189 · Cited by 1,026
GEMDOCK: A generic evolutionary method for molecular docking
Yang, J., & Chen, C. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20035 · Cited by 687
Berger, J., Hauber, J., Hauber, R., Geiger, R., & Cullen, B. R. (1988) · Gene · doi:10.1016/0378-1119(88)90219-3 · Cited by 667
Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA
Chen, F. E., Huang, D.-B., Chen, Y.-Q., & Ghosh, G. (1998) · Nature · doi:10.1038/34956 · Cited by 610
Structure of NF-κB p50 homodimer bound to a κB site
Ghosh, G., Duyne, G. V., Ghosh, S., & Sigler, P. B. (1995) · Nature · doi:10.1038/373303a0 · Cited by 568
Structure of the NF-κB p50 homodimer bound to DNA
Müller, C. W., Rey, F. A., Sodeoka, M., Verdine, G. L., & Harrison, S. C. (1995) · Nature · doi:10.1038/373311a0 · Cited by 535
Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones
Garcı́a-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 407
Pineda-Molina, E., Klatt, P., Vázquez, J., Marina, A., García de Lacoba, M., Pérez-Sala, D., & Lamas, S. (2001) · Biochemistry · doi:10.1021/bi011459o · Cited by 389
Xia, Y.-F., Ye, B.-Q., Li, Y.-D., Wang, J.-G., He, X.-J., Lin, X., Yao, X., Ma, D., Slungaard, A., Hebbel, R. P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4207 · Cited by 378
Self-citationCovalent Modifiers: An Orthogonal Approach to Drug Design
Potashman, M. H., & Duggan, M. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8008597 · Cited by 346
Regulation of DNA binding by Rel/NF-κB transcription factors: structural views
Chen, F. E., & Ghosh, G. (1999) · Oncogene · doi:10.1038/sj.onc.1203224 · Cited by 301
Electrophilic natural products and their biological targets
Gersch, M., Kreuzer, J., & Sieber, S. A. (2012) · Natural Product Reports · doi:10.1039/c2np20012k · Cited by 282
Lim, J. C. W., Chan, T. K., Ng, D. S., Sagineedu, S. R., Stanslas, J., & Wong, W. F. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05633.x · Cited by 268
Self-citationBao, Z., Guan, S., Cheng, C., Wu, S., Wong, S. H., Kemeny, D. M., Leung, B. P., & Wong, W. S. F. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1516oc · Cited by 226
Self-citationKumar, S., Rabson, A. B., & Gélinas, C. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.7.3094 · Cited by 165
Avonto, C., Taglialatela‐Scafati, O., Pollastro, F., Minassi, A., Di Marzo, V., De Petrocellis, L., & Appendino, G. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005959 · Cited by 158
Prediction of Michael-Type Acceptor Reactivity toward Glutathione
Schwöbel, J. A. H., Wondrousch, D., Koleva, Y. K., Madden, J. C., Cronin, M. T. D., & Schüürmann, G. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100172x · Cited by 135
A Structural Guide to Proteins of the NF- B Signaling Module
Huxford, T., & Ghosh, G. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000075 · Cited by 131
Reversible Michael addition of thiols as a new tool for dynamic combinatorial chemistry
Shi, B., & Greaney, M. F. (2005) · Chemical Communications · doi:10.1039/b414300k · Cited by 129
Pande, V., & Ramos, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363180 · Cited by 125
Mechanism of κB DNA binding by Rel/NF-κB dimers
Phelps, C. B., Sengchanthalangsy, L. L., Malek, S., & Ghosh, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003784200 · Cited by 122
Wang, J., Tan, X. F., Nguyễn, V. S., Yang, P., Zhou, J., Gao, M., Li, Z., Lim, T. K., He, Y., Ong, C. S., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.029793 · Cited by 120
Self-citationThe X-ray Crystal Structure of the NF-κB p50·p65 Heterodimer Bound to the Interferon β-κB Site
Berkowitz, B., Huang, D.-B., Chen-Park, F. E., Sigler, P. B., & Ghosh, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200006200 · Cited by 112
Na, H., & Surh, Y. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20225 · Cited by 111
Franco, M., Seyfried, N. T., Brand, A. H., Peng, J., & Mayor, U. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002188 · Cited by 109
Schmidt, T. J., Lyß, G., Pahl, H. L., & Merfort, I. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00234-5 · Cited by 87
NF-κB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets
Chen, Y., Sengchanthalangsy, L. L., Hackett, A., & Ghosh, G. (2000) · Structure · doi:10.1016/s0969-2126(00)00123-4 · Cited by 86
Chen, H., Lin, A., Chu, H.-C., Li, C., Tsai, C.-W., Chao, C., Wang, C., Lii, C., & Liu, K. (2011) · Journal of Natural Products · doi:10.1021/np200631v · Cited by 84
New substituted C-19-andrographolide analogues with potent cytotoxic activities
Sirion, U., Kasemsook, S., Suksen, K., Piyachaturawat, P., Suksamrarn, A., & Saeeng, R. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.085 · Cited by 82
Wang, Y.-J., Wang, J.-T., Fan, Q.-X., & Geng, J.-G. (2007) · Cell Research · doi:10.1038/cr.2007.89 · Cited by 80
Self-citationChandrasekaran, C. V., Thiyagarajan, P., Deepak, H. B., & Agarwal, A. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.009 · Cited by 71
Guan, S.-P., Kong, L. R., Chang, C. K., Lim, J. C. W., & Wong, W. S. F. (2011) · Journal of Natural Products · doi:10.1021/np2002572 · Cited by 68
Self-citationDas, B., Chowdhury, C., Kumar, D., Sen, R., Roy, R., Das, P., & Chatterjee, M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.126 · Cited by 63
Dey, S. K., Bose, D., Hazra, A., Naskar, S., Nandy, A., Munda, R. N., Das, S., Chatterjee, N., Mondal, N. B., Banerjee, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058055 · Cited by 58
Andrographolide Inhibits Oral Squamous Cell Carcinogenesis through NF-κB Inactivation
Wang, L.-J., Zhou, X., Wang, W., Tang, F., Qi, C., Yang, X., Wu, S., Lin, Y., Wang, J.-T., & Geng, J. (2011) · Journal of Dental Research · doi:10.1177/0022034511418341 · Cited by 53
Self-citationDirect Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B
Pande, V., Sousa, S. F., & Ramos, M. J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789578222 · Cited by 30
Molecular Interaction between Andrographolide and Glutathione Follows Second Order Kinetics
Zhang, Z., Chan, G. K.-L., Li, J., Fong, W. F., & Cheung, H. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1229 · Cited by 21
Campodónico, P. R., & Contreras, R. R. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.12.018 · Cited by 18
Wong, C. C., Sagineedu, S. R., Sumon, S. H., Sidik, S. M., Phillips, R. M., Lajis, N. H., & Stanslas, J. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.07.016 · Cited by 16
Mel’chin, V. V., & Butin, A. V. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.04.081 · Cited by 14
Yao, H. Q., Li, S., Yu, P., Tang, X., Jiang, J., & Wang, Y. (2012) · Molecules · doi:10.3390/molecules17010728 · Cited by 11
Research works printed but not linked: 3
- Kumar S., 1992, Mol. Cell. Biol., 12, 3094
- Jeong J., 2011, Mol. Cell. Proteomics, 10, 1
- Schüttelkopf A. W., 2004, Acta Crystallogr., 60, 1355
Cited by
Tan, W. S. D., Liao, W., Zhou, S., & Wong, W. S. F. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.024 · Cited by 177
Self-citationShi, T., Huang, Y., Chen, C.-C., Pi, W., Hsu, Y.-L., Lo, L., Chen, W., Fu, S., & Lin, C. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.086 · Cited by 140
Wang, J., Gao, L., Lee, Y. M., Kalesh, K., Ong, Y. S., Lim, J., Jee, J., Sun, H., Lee, S. S., Hua, Z., et al. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.010 · Cited by 138
“Andro is a labdane diterpene lactone isolated from the leaves of the plant Andrographis paniculata, and has been utilized for the treatments against HIV and acute upper respiratory tract infection (J. Chang et al., 2008; Nguyen et al., 2015).”
BackgroundSelf-citationLabdane diterpenoids as potential anti-inflammatory agents
Tran, Q. T. N., Wong, W. S. F., & Chai, C. L. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.019 · Cited by 118
Self-citationThe design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
“Nguyen VS, Loh XY, Wijaya H, Wang J, Lin Q, Lam Y, et al. Specificity and inhibitory mechanism of andrographolide and its analogues as antiasthma agents on NF-κB p50.”
BackgroundInfluential
Metadata
- Authors
- Nguyen, V. S., Loh, X. Y., Wijaya, H., Wang, J., Lin, Q., Lam, Y., Wong, W.-S. F., & Mok, Y. K.
- Affiliations
- Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore 117543
- National University of Singapore (SG)
- Corresponding author
- Mok, Yu Keung
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-01-23
- Volume
- 78
- Issue
- 2
- Pages
- 208-217
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2329411550
- Cited by
- 66
- References
- 45
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 16 · 2021: 3 · 2020: 11 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 1
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Natural Products (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National University of Singapore (R-184-000-193-646)
- Biomedical Research Council - A STAR (BMRC/09/1/21/19/595)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Andrographolide Research and Applications
- Physical Sciences › Chemistry › Organic Chemistry › Sesquiterpenes and Asteraceae Studies
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- andrographolide, NF-κB p50, covalent drug design, Michael addition, 14-deoxy-11,12-didehydroandrographolide, diterpenoid lactones, protein-ligand binding mechanism, cytotoxicity
- MeSH terms
- Cysteine, Diterpenes, Oxidation-Reduction, Molecular Structure, NF-kappa B, Anti-Asthmatic Agents, Andrographis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.